Suklabaidya S - Search Results

1

Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia.

Suklabaidya S, Das B, Ali SA, Jain S, Swaminathan S, Mohanty AK, Panda SK, Dash P, Chakraborty S, Batra SK, Senapati S. Suklabaidya S, et al. Oncotarget. 2016 Jul 5;7(27):41825-41842. doi: 10.18632/oncotarget.9729. Oncotarget. 2016. PMID: 27259232 Free PMC article.

2

Experimental models of pancreatic cancer desmoplasia.

Suklabaidya S, Dash P, Das B, Suresh V, Sasmal PK, Senapati S. Suklabaidya S, et al. Lab Invest. 2018 Jan;98(1):27-40. doi: 10.1038/labinvest.2017.127. Epub 2017 Nov 20. Lab Invest. 2018. PMID: 29155423 Free article. Review.

3

Pancreatic fibroblast exosomes regulate survival of cancer cells.

Suklabaidya S, Dash P, Senapati S. Suklabaidya S, et al. Oncogene. 2017 Jun 22;36(25):3648-3649. doi: 10.1038/onc.2016.528. Epub 2017 Feb 6. Oncogene. 2017. PMID: 28166198 No abstract available.

4

TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells.

Jain S, Suklabaidya S, Das B, Raghav SK, Batra SK, Senapati S. Jain S, et al. Among authors: suklabaidya s. Prostate. 2015 Jul 1;75(10):1020-33. doi: 10.1002/pros.22983. Epub 2015 Apr 2. Prostate. 2015. PMID: 25833062

5

MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis.

Suresh V, Dash P, Suklabaidya S, Murmu KC, Sasmal PK, Jogdand GM, Parida D, Sethi M, Das B, Mohapatra D, Saha S, Prasad P, Satoskar A, Senapati S. Suresh V, et al. Among authors: suklabaidya s. FASEB J. 2022 Aug;36(8):e22449. doi: 10.1096/fj.202101953R. FASEB J. 2022. PMID: 35839070

6

Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice.

Barman PK, Mukherjee R, Prusty BK, Suklabaidya S, Senapati S, Ravindran B. Barman PK, et al. Among authors: suklabaidya s. Cell Death Dis. 2016 May 12;7(5):e2224. doi: 10.1038/cddis.2016.131. Cell Death Dis. 2016. PMID: 27171266 Free PMC article.

7

Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells.

Sarkar S, Jain S, Rai V, Sahoo DK, Raha S, Suklabaidya S, Senapati S, Rangnekar VM, Maiti IB, Dey N. Sarkar S, et al. Among authors: suklabaidya s. Front Plant Sci. 2015 Oct 7;6:822. doi: 10.3389/fpls.2015.00822. eCollection 2015. Front Plant Sci. 2015. PMID: 26500666 Free PMC article.

8

Urinary bladder stone associated with seminal vesicle and prostate infection in a Copenhagen rat.

Senapati S, Suklabaidya S, Mallik H, Panda S, Hota D, Baisakh MR. Senapati S, et al. Among authors: suklabaidya s. J Nat Sci Biol Med. 2016 Jul-Dec;7(2):193-7. doi: 10.4103/0976-9668.184711. J Nat Sci Biol Med. 2016. PMID: 27433075 Free PMC article.

9

Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancreatic cancer cells.

Katoch A, Suklabaidya S, Chakraborty S, Nayak D, Rasool RU, Sharma D, Mukherjee D, Faheem MM, Kumar A, Sharma PR, Senapati S, Kumar LD, Goswami A. Katoch A, et al. Among authors: suklabaidya s. Mol Carcinog. 2018 Sep;57(9):1102-1115. doi: 10.1002/mc.22828. Epub 2018 May 15. Mol Carcinog. 2018. PMID: 29672923

10

Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo.

Parhi P, Suklabaidya S, Kumar Sahoo S. Parhi P, et al. Among authors: suklabaidya s. Sci Rep. 2017 Jul 19;7(1):5806. doi: 10.1038/s41598-017-05296-y. Sci Rep. 2017. PMID: 28724926 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters